MBX Biosciences, Inc.MBX
Price (close)
$55.39
Market cap
$2.7B
P/E
—
Revenue (TTM)
—
Net income
-$104.3M
Dividend yield
—
1-year total return
219.6%
Net margin
—
Revenue growth
—
Debt / equity
—
What MBX Biosciences, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net income | — | -$32.6M | -$61.9M | -$87.0M |
| Free cash flow | — | -$32.1M | -$55.6M | -$81.9M |
More on MBX.
- MBX Biosciences, Inc. summary
- MBX Biosciences, Inc. financial statements
- MBX Biosciences, Inc. key metrics
- MBX Biosciences, Inc. health scores and style box
- MBX Biosciences, Inc. earnings
- MBX Biosciences, Inc. dividends
- MBX Biosciences, Inc. valuation
- MBX Biosciences, Inc. ownership and insiders
- MBX Biosciences, Inc. peers
Figures from MBX Biosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.